Northcoast Research Analysts Lower Earnings Estimates for Henry Schein Inc. (HSIC)
Henry Schein Inc. (NASDAQ:HSIC) – Northcoast Research cut their Q2 2017 earnings per share (EPS) estimates for Henry Schein in a report issued on Thursday. Northcoast Research analyst E. Snyder now expects that the firm will post earnings per share of $1.77 for the quarter, down from their prior estimate of $1.78. Northcoast Research also issued estimates for Henry Schein’s Q3 2017 earnings at $1.84 EPS, Q4 2017 earnings at $2.05 EPS and FY2017 earnings at $7.26 EPS.
HSIC has been the subject of a number of other research reports. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, September 20th. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a research report on Tuesday, October 11th. Robert W. Baird downgraded shares of Henry Schein from an “outperform” rating to a “neutral” rating and decreased their price objective for the company from $176.00 to $164.00 in a research report on Friday, October 14th. Finally, Bank of America Corp. began coverage on shares of Henry Schein in a research report on Monday, September 12th. They issued a “buy” rating and a $185.00 price objective for the company. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the stock. Henry Schein has a consensus rating of “Hold” and an average target price of $159.50.
Henry Schein (NASDAQ:HSIC) traded up 0.12% during mid-day trading on Monday, reaching $153.53. 59,072 shares of the company were exchanged. Henry Schein has a 12-month low of $142.64 and a 12-month high of $183.00. The stock has a market capitalization of $12.56 billion, a price-to-earnings ratio of 26.01 and a beta of 1.05. The company’s 50 day moving average price is $161.57 and its 200-day moving average price is $169.75.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.63 by $0.01. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.46 earnings per share.
A number of large investors have recently bought and sold shares of the company. Ngam Advisors L.P. acquired a new stake in Henry Schein during the first quarter worth $1,749,000. Meiji Yasuda Asset Management Co Ltd. raised its stake in Henry Schein by 60.0% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,586 shares of the company’s stock worth $446,000 after buying an additional 970 shares during the last quarter. Canada Pension Plan Investment Board raised its stake in Henry Schein by 214.1% in the first quarter. Canada Pension Plan Investment Board now owns 26,101 shares of the company’s stock worth $4,506,000 after buying an additional 17,791 shares during the last quarter. Zebra Capital Management LLC raised its stake in Henry Schein by 30.4% in the first quarter. Zebra Capital Management LLC now owns 7,854 shares of the company’s stock worth $1,356,000 after buying an additional 1,833 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in Henry Schein during the first quarter worth $481,000. 92.03% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the sale, the director now directly owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.